MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.970
-0.140 (-3.41%)
Sep 10, 2026, 12:17 PM EDT - Market open
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $252.89 million as of September 10, 2026. Its market cap has increased by 100.07% in one year.
Market Cap
252.89M
Enterprise Value
114.68M
1-Year Change
100.07%
Ranking
Category
Stock Price
$3.97
ChartMarket Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $252.89M, a decrease of -57.87%. That is a compound annual growth rate of -6.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 275.20M | 170.33% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 291.46M |
| ProQR Therapeutics | 289.30M |
| Foghorn Therapeutics | 286.83M |
| AC Immune | 277.40M |
| ALX Oncology Holdings | 276.55M |
| Camp4 Therapeutics | 276.11M |
| Alector | 275.79M |
| Lineage Cell Therapeutics | 275.67M |